Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Langmuir ; 39(49): 17770-17781, 2023 12 12.
Article in English | MEDLINE | ID: mdl-38039387

ABSTRACT

Applications of nanoparticles (NPs) in nanodrugs, food additives, and cosmetics can result in the presence of nanomaterials in the human circulatory system and their attachment to red blood cells (RBCs), which may lead to cytotoxic effects. To investigate the interactions of NPs with RBC membranes (RBCm), supported erythrocyte membranes (SRBCm) were developed on piezoelectric sensors in a quartz crystal microbalance with dissipation (QCM-D) at 25 °C. A well-dispersed RBCm suspension at 1 mM NaCl and 0.2 mM NaHCO3 was obtained from whole blood and comprised colloidal membrane fragments with the average hydrodynamic diameter and zeta potential of 390 nm and -0.53 mV, respectively, at pH 7.0. The thin and rigid SRBCm was formed mainly through the deposition of RBCm fragments on the poly-l-lysine-modified crystal sensor, leading to the average frequency shift of -26.2 Hz and the low ratio of the dissipation to frequency shift (7.2 × 10-8 Hz-1). The complete coverage of SRBCm was indicated by the plateau of the frequency shift in the stage of SRBCm formation and no deposition of negatively charged 106 nm polystyrene nanoparticles (PSNPs) on the SRBCm. Atomic force microscopy and immunofluorescence microscopy images showed that RBCm aggregates with the average size of 420 nm and erythrocyte membrane proteins existed on SRBCm, respectively. The methods of determining attachment efficiencies of model positively charged NPs (i.e., hematite NPs or HemNPs) and model negatively charged NPs (i.e., PSNPs) on SRBCm were demonstrated in 1 mM NaCl solution at pH 5.1 and pH 7.0, respectively. HemNPs exhibited a favorable deposition with an attachment efficiency of 0.99 while PSNPs did not show any attachment propensity toward SRBCm.


Subject(s)
Nanoparticles , Nanostructures , Humans , Sodium Chloride , Nanoparticles/chemistry , Erythrocyte Membrane , Quartz Crystal Microbalance Techniques
2.
Int J Mol Sci ; 22(11)2021 May 26.
Article in English | MEDLINE | ID: mdl-34073419

ABSTRACT

Specific adhesion of P. falciparum parasite-infected erythrocytes (IE) in deep vascular beds can result in severe complications, such as cerebral malaria, placental malaria, respiratory distress, and severe anemia. Cerebral malaria and severe malaria syndromes were associated previously with sequestration of IE to a microvasculature receptor ICAM-1. The screening of Torrey Pines Scaffold Ranking library, which consists of more than 30 million compounds designed around 75 molecular scaffolds, identified small molecules that inhibit cytoadhesion of ICAM-1-binding IE to surface-immobilized receptor at IC50 range down to ~350 nM. With their low cytotoxicity toward erythrocytes and human endothelial cells, these molecules might be suitable for development into potentially effective adjunct anti-adhesion drugs to treat cerebral and/or severe malaria syndromes. Our two-step high-throughput screening approach is specifically designed to work with compound mixtures to make screening and deconvolution to single active compounds fast and efficient.


Subject(s)
Antimalarials , Erythrocytes , Intercellular Adhesion Molecule-1/metabolism , Malaria, Falciparum , Plasmodium falciparum/metabolism , Small Molecule Libraries , Antimalarials/chemistry , Antimalarials/pharmacology , Erythrocytes/metabolism , Erythrocytes/parasitology , Erythrocytes/pathology , Humans , Malaria, Falciparum/drug therapy , Malaria, Falciparum/metabolism , Malaria, Falciparum/pathology , Small Molecule Libraries/chemistry , Small Molecule Libraries/pharmacology
3.
J Proteomics ; 234: 104083, 2021 03 15.
Article in English | MEDLINE | ID: mdl-33373718

ABSTRACT

Using high-throughput BioPlex assays, we determined that six fractions from the venom of Conus nux inhibit the adhesion of various recombinant PfEMP-1 protein domains (PF08_0106 CIDR1α3.1, PF11_0521 DBL2ß3, and PFL0030c DBL3X and DBL5e) to their corresponding receptors (CD36, ICAM-1, and CSA, respectively). The protein domain-receptor interactions permit P. falciparum-infected erythrocytes (IE) to evade elimination in the spleen by adhering to the microvasculature in various organs including the placenta. The sequences for the main components of the fractions, determined by tandem mass spectrometry, yielded four T-superfamily conotoxins, one (CC-Loop-CC) with I-IV, II-III connectivity and three (CC-Loop-CXaaC) with a I-III, II-IV connectivity. The 3D structure for one of the latter, NuxVA = GCCPAPLTCHCVIY, revealed a novel scaffold defined by double turns forming a hairpin-like structure stabilized by the two disulfide bonds. Two other main fraction components were a miniM conotoxin, and a O2-superfamily conotoxin with cysteine framework VI/VII. This study is the first one of its kind suggesting the use of conotoxins for developing pharmacological tools for anti-adhesion adjunct therapy against malaria. Similarly, mitigation of emerging diseases like AIDS and COVID-19, can also benefit from conotoxins as inhibitors of protein-protein interactions as treatment. BIOLOGICAL SIGNIFICANCE: Among the 850+ species of cone snail species there are hundreds of thousands of diverse venom exopeptides that have been selected throughout several million years of evolution to capture prey and deter predators. They do so by targeting several surface proteins present in target excitable cells. This immense biomolecular library of conopeptides can be explored for potential use as therapeutic leads against persistent and emerging diseases affecting non-excitable systems. We aim to expand the pharmacological reach of conotoxins/conopeptides by revealing their in vitro capacity to disrupt protein-protein and protein-polysaccharide interactions that directly contribute to pathology of Plasmodium falciparum malaria. This is significant for severe forms of malaria, which might be deadly even after treated with current parasite-killing drugs because of persistent cytoadhesion of P. falciparum infected erythrocytes even when parasites within red blood cells are dead. Anti-adhesion adjunct drugs would de-sequester or prevent additional sequestration of infected erythrocytes and may significantly improve survival of malaria patients. These results provide a lead for further investigations into conotoxins and other venom peptides as potential candidates for anti-adhesion or blockade-therapies. This study is the first of its kind and it suggests that conotoxins can be developed as pharmacological tools for anti-adhesion adjunct therapy against malaria. Similarly, mitigation of emerging diseases like AIDS and COVID-19, can also benefit from conotoxins as potential inhibitors of protein-protein interactions as treatment.


Subject(s)
CD36 Antigens , DNA Repair Enzymes , Erythrocytes , Intercellular Adhesion Molecule-1 , Mollusk Venoms , Plasmodium falciparum , Transcription Factors , Animals , CD36 Antigens/chemistry , CD36 Antigens/metabolism , COVID-19 , Conus Snail , DNA Repair Enzymes/chemistry , DNA Repair Enzymes/metabolism , Erythrocytes/chemistry , Erythrocytes/metabolism , Erythrocytes/parasitology , Humans , Intercellular Adhesion Molecule-1/chemistry , Intercellular Adhesion Molecule-1/metabolism , Mollusk Venoms/chemistry , Mollusk Venoms/pharmacology , Plasmodium falciparum/chemistry , Plasmodium falciparum/metabolism , Protein Domains , Protozoan Proteins , SARS-CoV-2 , Transcription Factors/chemistry , Transcription Factors/metabolism
4.
Nature ; 582(7810): 104-108, 2020 06.
Article in English | MEDLINE | ID: mdl-32427965

ABSTRACT

Malaria caused by Plasmodium falciparum remains the leading single-agent cause of mortality in children1, yet the promise of an effective vaccine has not been fulfilled. Here, using our previously described differential screening method to analyse the proteome of blood-stage P. falciparum parasites2, we identify P. falciparum glutamic-acid-rich protein (PfGARP) as a parasite antigen that is recognized by antibodies in the plasma of children who are relatively resistant-but not those who are susceptible-to malaria caused by P. falciparum. PfGARP is a parasite antigen of 80 kDa that is expressed on the exofacial surface of erythrocytes infected by early-to-late-trophozoite-stage parasites. We demonstrate that antibodies against PfGARP kill trophozoite-infected erythrocytes in culture by inducing programmed cell death in the parasites, and that vaccinating non-human primates with PfGARP partially protects against a challenge with P. falciparum. Furthermore, our longitudinal cohort studies showed that, compared to individuals who had naturally occurring anti-PfGARP antibodies, Tanzanian children without anti-PfGARP antibodies had a 2.5-fold-higher risk of severe malaria and Kenyan adolescents and adults without these antibodies had a twofold-higher parasite density. By killing trophozoite-infected erythrocytes, PfGARP could synergize with other vaccines that target parasite invasion of hepatocytes or the invasion of and egress from erythrocytes.


Subject(s)
Apoptosis/immunology , Intercellular Signaling Peptides and Proteins/immunology , Malaria, Falciparum/immunology , Malaria, Falciparum/prevention & control , Parasites/immunology , Plasmodium falciparum/cytology , Plasmodium falciparum/immunology , Protozoan Proteins/immunology , Adolescent , Adult , Animals , Antibodies, Protozoan/immunology , Antigens, Protozoan/chemistry , Antigens, Protozoan/immunology , Aotidae/immunology , Aotidae/parasitology , Caspases/metabolism , Child , Cohort Studies , DNA, Protozoan/chemistry , DNA, Protozoan/metabolism , Enzyme Activation , Erythrocytes/parasitology , Female , Humans , Intercellular Signaling Peptides and Proteins/chemistry , Kenya , Malaria Vaccines/immunology , Malaria, Falciparum/parasitology , Male , Mice , Parasites/cytology , Parasites/growth & development , Plasmodium falciparum/growth & development , Protozoan Proteins/chemistry , Tanzania , Trophozoites/cytology , Trophozoites/growth & development , Trophozoites/immunology , Vacuoles/immunology
5.
Sci Rep ; 9(1): 2901, 2019 02 27.
Article in English | MEDLINE | ID: mdl-30814636

ABSTRACT

Tandem Oligonucleotide Repeat Cascade Amplification (TORCA) based on signal rather than target amplification under isothermal conditions was developed for nucleic acid assays. The initial signal was generated by hybridization of single stranded DNA targets to immobilized recognition probes followed by hybrid cleavage with specific restriction endonuclease (REase), and release of trigger oligonucleotides (Tr1). The signal amplification chamber contained two bead types carrying single-stranded amplification probes and two amplification REases. The probes consisted of multiple tandem repeats of either Tr1 or another trigger Tr2, with the tandem-Tr1 anchored to the beads through the antisense Tr2 linker and vice versa. Addition of the recognition reaction solution and Tr1 hybridization to the anti-Tr1 linkers started cleavage and release of additional Tr1 and Tr2, resulting in exponential signal amplification. The cleavage cascade also released horseradish peroxidase (HRP) pre-attached to the amplification probes, and the resultant signal was measured colorimetrically. A TORCA assay was developed for detection of Plasmodium falciparum parasites in blood. It had the detection limit in the attomolar concentration range, successfully detecting sub-microscopic P. falciparum infections at less than 0.75 infected erythrocytes per microliter. Further TORCA optimization will likely produce the quantitative isothermal alternative to PCR at a fraction of its cost.


Subject(s)
Blood/parasitology , Erythrocytes/parasitology , Malaria, Falciparum/diagnosis , Nucleic Acid Amplification Techniques/methods , Plasmodium falciparum/genetics , Erythrocytes/pathology , Humans , Limit of Detection , Microscopy , Molecular Diagnostic Techniques , Tandem Repeat Sequences/genetics
6.
Sci Rep ; 8(1): 17871, 2018 12 14.
Article in English | MEDLINE | ID: mdl-30552383

ABSTRACT

Major complications and mortality from Plasmodium falciparum malaria are associated with cytoadhesion of parasite-infected erythrocytes (IE). The main parasite ligands for cytoadhesion are members of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) family. Interactions of different host receptor-ligand pairs may lead to various pathological outcomes, like placental or cerebral malaria. It has been shown previously that IE can bind integrin αVß3. Using bead-immobilized PfEMP1 constructs, we have identified that the PFL2665c DBLδ1_D4 domain binds to αVß3 and αVß6. A parasite line expressing PFL2665c binds to surface-immobilized αVß3 and αVß6; both are RGD motif-binding integrins. Interactions can be inhibited by cyloRGDFV peptide, an antagonist of RGD-binding integrins. This is a first, to the best of our knowledge, implication of a specific PfEMP1 domain for binding to integrins. These host receptors have important physiological functions in endothelial and immune cells; therefore, these results will contribute to future studies and a better understanding, at the molecular level, of the physiological outcome of interactions between IE and integrin receptors on the surface of host cells.


Subject(s)
Antigens, Neoplasm/metabolism , Cell Adhesion , Erythrocytes/physiology , Erythrocytes/parasitology , Integrin alphaVbeta3/metabolism , Integrins/metabolism , Plasmodium falciparum/growth & development , Protozoan Proteins/metabolism , Humans , Protein Binding
7.
Infect Immun ; 86(8)2018 08.
Article in English | MEDLINE | ID: mdl-29784862

ABSTRACT

Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) mediates parasite sequestration to the cerebral microvasculature via binding of DBLß domains to intercellular adhesion molecule 1 (ICAM1) and is associated with severe cerebral malaria. In a cohort of 187 young children from Papua New Guinea (PNG), we examined baseline levels of antibody to the ICAM1-binding PfEMP1 domain, DBLß3PF11_0521, in comparison to four control antigens, including NTS-DBLα and CIDR1 domains from another group A variant and a group B/C variant. Antibody levels for the group A antigens were strongly associated with age and exposure. Antibody responses to DBLß3PF11_0521 were associated with a 37% reduced risk of high-density clinical malaria in the follow-up period (adjusted incidence risk ratio [aIRR] = 0.63 [95% confidence interval {CI}, 0.45 to 0.88; P = 0.007]) and a 25% reduction in risk of low-density clinical malaria (aIRR = 0.75 [95% CI, 0.55 to 1.01; P = 0.06]), while there was no such association for other variants. Children who experienced severe malaria also had significantly lower levels of antibody to DBLß3PF11_0521 and the other group A domains than those that experienced nonsevere malaria. Furthermore, a subset of PNG DBLß sequences had ICAM1-binding motifs, formed a distinct phylogenetic cluster, and were similar to sequences from other areas of endemicity. PfEMP1 variants associated with these DBLß domains were enriched for DC4 and DC13 head structures implicated in endothelial protein C receptor (EPCR) binding and severe malaria, suggesting conservation of dual binding specificities. These results provide further support for the development of specific classes of PfEMP1 as vaccine candidates and as biomarkers for protective immunity against clinical P. falciparum malaria.


Subject(s)
Antibodies, Protozoan/blood , Antigens, Protozoan/immunology , Biomarkers/blood , Malaria, Falciparum/immunology , Protozoan Proteins/immunology , Antigens, Protozoan/genetics , Child, Preschool , Endothelial Protein C Receptor/metabolism , Female , Follow-Up Studies , Genetic Variation , Humans , Incidence , Infant , Intercellular Adhesion Molecule-1/metabolism , Malaria, Falciparum/epidemiology , Malaria, Falciparum/pathology , Male , Papua New Guinea/epidemiology , Phylogeny , Protein Binding , Protein Domains/immunology , Protozoan Proteins/genetics , Risk Assessment
8.
Sci Rep ; 6: 24508, 2016 Apr 13.
Article in English | MEDLINE | ID: mdl-27072056

ABSTRACT

Placental malaria caused by Plasmodium falciparum contributes to ~200,000 child deaths annually, mainly due to low birth weight (LBW). Parasitized erythrocyte sequestration and consequent inflammation in the placenta are common attributes of placental malaria. The precise molecular details of placental changes leading to LBW are still poorly understood. We hypothesized that placental malaria may disturb maternofetal exchange of vitamins, lipids, and hormones mediated by the multi-ligand (n ~ 50) scavenging/signaling receptor megalin, which is abundantly expressed in placenta but was not previously analyzed in pregnancy outcomes. We studied abundance of megalin and its intracellular adaptor protein Dab2 by immunofluorescence microscopy in placental biopsies from Ugandan women with (n = 8) and without (n = 20) active placental malaria. We found that: (a) abundances of both megalin (p = 0.01) and Dab2 (p = 0.006) were significantly reduced in brush border of syncytiotrophoblast of infected placentas; (b) amounts of megalin and Dab2 were strongly correlated (Spearman's r = 0.53, p = 0.003); (c) abundances of megalin and Dab2 (p = 0.046) were reduced in infected placentas from women with LBW deliveries. This study provides first evidence that placental malaria infection is associated with reduced abundance of megalin transport/signaling system and indicate that these changes may contribute to the pathology of LBW.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Infant, Low Birth Weight , Low Density Lipoprotein Receptor-Related Protein-2/metabolism , Malaria, Falciparum/metabolism , Placenta Diseases/metabolism , Trophoblasts/metabolism , Tumor Suppressor Proteins/metabolism , Apoptosis Regulatory Proteins , Female , Humans , Malaria, Falciparum/pathology , Pregnancy , Pregnancy Outcome
9.
J Infect Dis ; 211(7): 1134-43, 2015 Apr 01.
Article in English | MEDLINE | ID: mdl-25355939

ABSTRACT

BACKGROUND: We developed a 2-step approach to screen molecules that prevent and/or reverse Plasmodium falciparum-infected erythrocyte (IE) binding to host receptors. IE adhesion and sequestration in vasculature causes severe malaria, and therefore antiadhesion therapy might be useful as adjunctive treatment. IE adhesion is mediated by the polymorphic family (approximately 60 members) of P. falciparum EMP1 (PfEMP1) multidomain proteins. METHODS: We constructed sets of PfEMP1 domains that bind ICAM-1, CSA, or CD36, receptors that commonly support IE binding. Combinations of domain-coated beads were assayed by Bio-Plex technology as a high-throughput molecular platform to screen antiadhesion molecules (antibodies and small molecules). Molecules identified as so-called hits in the screen (first step) then could be assayed individually for inhibition of binding of live IE to receptors (second step). RESULTS: In proof-of-principle studies, the antiadhesion activity of several antibodies was concordant in Bio-Plex and live IE assays. Using this 2-step approach, we identified several molecules in a small molecule library of 10 000 compounds that could inhibit and reverse binding of IEs to ICAM-1 and CSA receptors. CONCLUSION: This 2-step screening approach should be efficient for identification of antiadhesion drug candidates for falciparum malaria.


Subject(s)
Cell Adhesion Molecules/metabolism , Erythrocytes/parasitology , Malaria, Falciparum/prevention & control , Plasmodium falciparum/drug effects , Protozoan Proteins/metabolism , CD36 Antigens/metabolism , Cell Adhesion/drug effects , Cell Adhesion/immunology , Cell Line , Erythrocytes/immunology , Erythrocytes/metabolism , High-Throughput Screening Assays , Humans , Intercellular Adhesion Molecule-1/metabolism , Malaria, Falciparum/immunology , Malaria, Falciparum/parasitology , Plasmodium falciparum/immunology , Small Molecule Libraries
SELECTION OF CITATIONS
SEARCH DETAIL
...